News

MyChesCo on MSN8h
ENHERTU Combination Shows Promising Results in HER2-Positive Metastatic Breast Cancer Trial
High-level results from the DESTINY-Breast09 Phase III trial revealed that ENHERTU® (fam-trastuzumab deruxtecan-nxki), in ...
A New Immune Treatment May Work Against Several Cancer Types
According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...
News-Medical.Net13h
Targeted drug zongertinib shows strong results for HER2-mutant lung cancer in clinical trial
The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...
HER2 targeted therapy shows promise in previously treated lung cancers
The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced ...
For some cancer patients, immunotherapy may be way to skip surgery and chemo
Cancer operations that remove whole or parts of an organ can be life-altering. New research suggests that some patients may ...